Publications by authors named "Fanny Cardon"

Claim this Profile
L
Larger quality-of-life gains with an asthma support app: a randomised controlled trial.
Arnaud Bourdin, Serena Casanova, Engi Ahmed, Benoit Brouard, Adrien Boher, Fanny Cardon

ERJ Open Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard patient training versus Vik-Asthme chatbot-guided training: 'AsthmaTrain' - a protocol for a randomised controlled trial for patients with asthma.
Carey Meredith Suehs, Isabelle Vachier, David Galeazzi, François Vaast, Fanny Cardon

BMJ Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol.
Fabien Huet, Quentin Delbaere, Sylvain Aguilhon, Valentin Dupasquier, Delphine Delseny, Fanny Cardon

Medicina (Kaunas)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
Christine Katlama, Lambert Assoumou, Marc-Antoine Valantin, Cathia Soulié, Esteban Martinez, Fanny Cardon

J Antimicrob Chemother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
Yves Lévy, Jean-Daniel Lelièvre, Lambert Assoumou, Esther Aznar, Federico Pulido, Fanny Cardon

Ann Intern Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
Christine Katlama, Lambert Assoumou, Marc-Antoine Valantin, Cathia Soulié, Esteban Martinez, Fanny Cardon

J Antimicrob Chemother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
Valérie Pourcher, Aude Desnoyer, Lambert Assoumou, Céleste Lebbe, Angélique Curjol, Fanny Cardon

AIDS Res Hum Retroviruses· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis